US FDA News: Statement on efforts to help make development of biosimilar and interchangeable insulin products more efficient

FDA issues guidance to help make development of biosimilar and interchangeable insulin products more efficient.
Read more: Statement on efforts to help make development of biosimilar and interchangeable insulin products more efficient